DIABETOLOGIA New research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD), held online this year, suggests that the widely used osteoporosis drug alendronate reduces the risk of type 2 diabetes. It has been known for decades that patients with diabetes have a higher risk of fractures – suggesting a...